期刊文献+

低分子量肝素用于急性肾功能衰竭血液透析治疗33例 被引量:6

下载PDF
导出
摘要 目的探讨低分子量肝素在急性肾功能衰竭血液透析治疗中的抗凝作用及护理策略。方法将急性肾功能衰竭需要血液透析的患者66例随机均分为两组。治疗组患者在血液透析时使用低分子量肝素抗凝,对照组患者使用普通肝素防止凝血。透析全过程中观察透析器及管道凝血情况,统计出血情况与穿刺点压迫止血时间。结果在血液透析中的出血率治疗组为0,对照组为9.09%;治疗组穿刺点压迫止血时间为(7.9±1.1)min,明显低于对照组的(12.2±1.0)min(P<0.05)。结论低分子量肝素用于急性肾功能衰竭血液透析治疗,具有预防凝血且不加重出血的良好效果,值得临床推广。
出处 《中国药业》 CAS 2013年第9期108-109,共2页 China Pharmaceuticals
  • 相关文献

参考文献6

二级参考文献75

  • 1丁苏青,胡艳芳,裴继云.血液透析中应用抗凝剂的探讨[J].中国血液净化,2002,1(2):26-28. 被引量:7
  • 2陈琨,黄坚,倪红英.高危出血倾向患者应用微剂量肝素抗凝连续性血液净化的治疗[J].中华急诊医学杂志,2004,13(6):419-420. 被引量:4
  • 3Franke A, Ktthl HE The role of antiplatelet agents in the management of patients receiving intracardiac closure devices. Curr Pharm Des 2006; 12: 1287-1291.
  • 4Jux H, Bertram P, Wohlsein M, Bruegmann M, Paul T. Interventional atrial septal defect closure using a totally bioresorbable occluder matrix: development and preclinical evaluation of the BioSTAR device. J Am Coll Cardiol 2006; 48: 161-169.
  • 5Dorrucci V, Griselli F, Petralia G. Spinamano L, Adornetto R. Heparin-bonded expanded polytetrafluoroethylene grafts for infragenicular bypass in patients with critical limb ischemia: 2-year results. J Cardiovasc Surg (Torino) 2008; 49: 145-149.
  • 6Anzai H, Child J, Natterson B, Krivokapich J, Fishbein MC, Chan VK, et al. Incidence of thrombus formation on the CardioSEAL and the Amplatzer interatrial closure devices. Am J Cardiol 2004; 93: 426-431.
  • 7Brandt RR, Neumann T, Neuzner J, Rau M, Faude I, Hamm CW. Transcatheter closure of atrial septal defect and patent foramen ovale in adult patients using the Amplatzer occlusion device: no evidence for thrombus deposition with antiplatelet agents. J Am Soc Echocardiogr 2002; 15 (10 Pt 1): 1094-1098.
  • 8Malafaya PB, Stappers F, Reis RL. Starch-based microspheres produced by emulsion crosslinking with a potential media dependent responsive behavior to be used as drug delivery carriers. J Mater Sci Mater Med 2006; 17: 371-377.
  • 9Sah HK, Toddywala R, Chien YW. Biodegradable microcapsules prepared by a w/o/w technique: effects of shear force to make a primary w/o emulsion on their morphology and protein release. J Microencapsul 1995; 12: 59-69.
  • 10Mukherjee B, Mahanti B, Panda R Mahapatra S. Preparation and evaluation of verapamil hydrochloride microcapsules. Am J Ther 2005; 12: 417-424.

共引文献24

同被引文献58

引证文献6

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部